Bloomberg Businessweek

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.
On this episode, hosts Carol Massar and Tim Stenovec speak to:
Yoni Assia, eToro CEO on eToro's earnings, the retail trading space and how AI could be reshaping it, and why he's bullish on Bitcoin and crypto
Silla Brush, Bloomberg News Investing Reporter & Kat Doherty, Bloomberg News Finance Reporter on US derivatives exchange CME creating a futures market for computing power
Chris Palmeri, Bloomberg News Senior Editor and Entertainment team leader on big media upfronts
Matt Atkenson, Ford Pro North America Sales & Operations Executive Director on small businesses

See omnystudio.com/listener for privacy information.

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.
On this episode of Bloomberg Businessweek Daily, hosts Carol Massar and Tim Stenovec speak with Bill Rauch and Zhailon Levingston, co-directors of 'Cats: The Jellice Ball' about their newly reimaging and relaunching of the beloved Broadway musical.
See omnystudio.com/listener for privacy information.

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.
On this episode of Bloomberg Businessweek Daily, hosts Carol Massar and Tim Stenovec speak with:
Jeff Kip, CEO of Angi on the company's latest earnings, AI efforts and its outlook on the housing market.
Denise Paulonis, Sally Beauty CEO and President on her company's results, why she thinks lower-end consumers are feeling pressure, and the company's TikTok and social media e-commerce strategies.
Amara Omeokwe, Bloomberg News Federal Reserve reporter on her Big Take and Businessweek feature: Powell Exits With Legacy Built on Central Bank Independence
See omnystudio.com/listener for privacy information.

Blackstone Life Sciences, which has some $17 billion in assets under management, typically invests in late-stage medicines invented by biotech and pharmaceutical companies in exchange for a royalty on future sales. In 2024, for example, the firm invested as much as $750 million in financing for Moderna’s flu vaccine development.

But Blackstone also wants to own a stake in some companies that it backs.
In late March, Blackstone closed its latest life-sciences fund with $6.3 billion of commitments, the firm’s biggest haul for backing clinical trials of medicines and technologies.

Dr. Jenny Rooke is Founder and Managing Director of Genoa Ventures. She discusses the cross between tech and health with Carol Massar and Tim Stenovec.
See omnystudio.com/listener for privacy information.

Featuring some of our favorite conversations of the week from our daily radio show “Bloomberg Businessweek Daily.”

Hosted by Carol Massar and Tim Stenovec Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 121, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio. You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News.

Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno and @BW
See omnystudio.com/listener for privacy information.